Skip to main content

Lamb Weston Holdings, Inc.

For the period ended Feb 22, 2026. Filed Apr 1, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Feb 22, 2026 · Filed Apr 1, 2026

LW$57.16+3.5%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Notes to Consolidated Financial Statements (Unaudited)

Condensed Notes to Consolidated Financial Statements

(Unaudited)

  1. NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Lamb Weston Holdings, Inc. (“we,” “us,” “our,” the “Company,” or “Lamb Weston”) is a leading global producer, distributor, and marketer of value-added frozen potato products; headquartered in Eagle, Idaho. We havetwo reportable segments: North America and International. See Note 13, Segments, for additional information on our reportable segments.

Basis of Presentation

The accompanying unaudited Consolidated Financial Statements present the financial results of Lamb Weston and its consolidated subsidiaries for the thirteen and thirty-nine weeks ended February 22, 2026 and February 23, 2025, and have been prepared in accordance with generally accepted accounting principles (“GAAP”) in the United States of America (“U.S.”).

These consolidated financial statements are unaudited and include all adjustments that we consider necessary for a fair presentation of such financial statements and consist only of normal recurring adjustments. The preparation of financial statements involves the use of estimates and accruals. The actual results that we experience may differ materially from those estimates. Results for interim periods should not be considered indicative of results for our full fiscal year, which ends the last Sunday in May.

These financial statements and related condensed notes should be read together with the consolidated financial statements and notes in our Annual Report on Form 10-K for the fiscal year ended May 25, 2025 (the “Form 10-K”), where we include additional information on our critical accounting estimates, policies, and the methods and assumptions used in our estimates. We filed the Form 10-K with the Securities and Exchange Commission (the “SEC”) on July 23, 2025.

Certain amounts from prior period consolidated financial statements have been reclassified to conform with current period presentation. These reclassifications had no financial impact on previously reported net income, cash flows, or stockholders’ equity.

Accounting Pronouncements

In December 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, to enhance transparency and decision usefulness of income tax disclosures, particularly around rate reconciliations and income taxes paid information. ASU 2023-09 is effective for our Annual Report on Form 10-K for the fiscal year ending May 31, 2026, on a prospective basis, with early adoption permitted. We adopted this guidance as of May 26, 2025, and will update disclosures within our fiscal 2026 Annual Report on Form 10-K.

In November 2024, the FASB issued ASU 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40), which requires companies to provide more detailed information of certain income statement expenses within the footnotes to the financial statements. ASU 2024-03 is effective for our Annual Report on Form 10-K for the fiscal year ending May 28, 2028, and for our quarterly reports beginning fiscal year 2029, on a prospective basis, with early adoption permitted. We are evaluating the impact of adopting this ASU on our consolidated financial statements and related disclosures.

In September 2025, the FASB issued ASU 2025-06, Intangibles - Goodwill and Other - Internal - Use Software (Subtopic 350-40): Targeted Improvements to Accounting for Internal-Use Software. This guidance provides criteria that must be met for entities to capitalize software development costs and factors to consider if there is significant uncertainty associated with the development activities of software. This guidance is effective for our annual reporting periods beginning with fiscal 2029 and interim periods within that fiscal year. Early adoption is permitted. We are currently evaluating the impact of adopting this ASU on our consolidated financial statements and related disclosures.

There were no other accounting pronouncements recently issued that had or are expected to have a material impact on our consolidated financial statements.

  1. EARNINGS PER SHARE

The following table sets forth the computation of basic and diluted earnings per common share for the periods presented:

Thirteen Weeks EndedThirty-Nine Weeks Ended
(in millions, except per share amounts)February 22,2026February 23,2025February 22,2026February 23,2025
Numerator:
Net income$54.0$146.0$180.4$237.3
Denominator:
Basic weighted average common shares outstanding139.0141.9139.3142.8
Add: Dilutive effect of employee incentive plans (a)0.30.50.30.4
Diluted weighted average common shares outstanding139.3142.4139.6143.2
Earnings per share:
Basic$0.39$1.03$1.30$1.66
Diluted$0.39$1.03$1.29$1.66

(a)Potential dilutive shares of common stock under employee incentive plans are determined by applying the treasury stock method to the assumed exercise of outstanding stock options and the assumed vesting of outstanding restricted stock units and performance awards. As of February 22, 2026 and February 23, 2025, we excluded 5.3 million and 0.6 million, respectively, of shares of stock-based awards from the computation of diluted earnings per share because they would be antidilutive.

  1. INCOME TAXES

Income tax expense for the periods presented were as follows:

Thirteen Weeks EndedThirty-Nine Weeks Ended
(in millions)February 22,2026February 23,2025February 22,2026February 23,2025
Income before income taxes and equity method earnings$81.6$201.4$289.3$343.5
Equity method investment earnings$2.7$2.1$5.3$15.5
Income tax expense$30.3$57.5$114.2$121.7
Effective tax rate (a)35.9%28.3%38.8%33.9%

(a)The effective income tax rate is calculated as the ratio of income tax expense to pre-tax income, inclusive of equity method investment earnings. The effective tax rate varies from the U.S. statutory tax rate of 21% principally due to the impact of U.S. state taxes, foreign taxes and currency, permanent differences, and discrete items.

Income Taxes Paid

Income taxes paid, net of refunds, were $100.9 million and $123.6 million during the thirty-nine weeks ended February 22, 2026 and February 23, 2025, respectively.

  1. COST SAVINGS PROGRAM AND RESTRUCTURING

We announced a cost savings program (the “Cost Savings Program”) in July 2025 and a restructuring plan (the “Restructuring Plan”) in October 2024. During fiscal 2026, we also undertook additional restructuring actions, including the permanent closure of certain production facilities to improve asset utilization in our International segment, and completed sales of certain non-core assets as part of our Focus to Win strategy. The restructuring activities undertaken in connection with these initiatives, including the Cost Savings Program and Restructuring Plan, are referred to collectively as the “Plans”.

Amounts classified as “Cost Savings Program and Restructuring expenses” on our Consolidated Statement of Earnings for fiscal 2026 primarily relate to costs associated with the Cost Savings Program, restructuring activities related to facility closures to improve asset utilization, and net gains related to certain non-core asset sales. Expenses recorded in fiscal 2025 relate solely to the Restructuring Plan.

We expect to recognize approximately $20 million of charges during the remainder of fiscal 2026 and $25 million to $50 million in fiscal 2027 in connection with the Plans.

For the thirteen weeks ended February 22, 2026, we recorded $55.5 million of pre-tax charges, of which $9.0 million were cash and $46.5 million were non-cash. For the thirty-nine weeks ended February 22, 2026, we recorded $101.5 million of pre-tax charges, of which $55.1 million were cash and $46.4 million were non-cash. Costs associated with the Plans were as follows:

Thirteen Weeks EndedThirty-Nine Weeks Ended
(in millions)February 22,2026February 23,2025February 22,2026February 23,2025
Cost Savings Program and Restructuring Plan expenses related to:
Retirement of assets and other plant charges (a)$46.9$7.2$48.7$53.0
Potato contract terminations (b)—(3.2)—61.5
Inventory write-off (b)7.33.97.323.7
Employee-related costs (c)6.10.715.116.9
Professional services and other5.81.741.014.3
66.110.3112.1169.4
Sale of non-core assets (a)(10.6)—(10.6)—
$55.5$10.3$101.5$169.4

(a)Includes charges related to write-off of assets at permanently closed production facilities under the Plans, impairments of certain non-core assets, and plant charges. The gain on the sale of non-core assets was $1.4 million.

(b)Includes the cost of contracted raw potatoes that were not used due to curtailed production under the Restructuring Plan and the write-off of inventories, including spare parts, related to production curtailments under the Plans.

(c)Includes employee severance and other one-time termination benefits related to reductions in headcount.

The following amounts are included within the following financial statement captions in the Company’s Consolidated Statements of Earnings:

Thirteen Weeks EndedThirty-Nine Weeks Ended
(in millions)February 22,2026February 23,2025February 22,2026February 23,2025
Cost Savings Program and Restructuring Plan expenses included in:
Cost of sales$7.3$0.7$6.9$76.2
Cost Savings Plan and Restructuring expenses48.29.694.684.2
Equity method investment earnings———9.0
$55.5$10.3$101.5$169.4

Accruals remaining under the Plans are recorded as current liabilities within “Accounts payable” and “Accrued liabilities” in the accompanying Consolidated Balance Sheet at February 22, 2026. The following is a roll-forward of accrued restructuring liabilities related to the Plans:

(in millions)
Accrued restructuring liability, May 25, 2025$21.5
Additions65.7
Payments(78.2)
Accrued restructuring liability, February 22, 2026$9.0
  1. INVENTORIES

Inventories are valued at the lower of cost (determined using the first-in, first-out method) or net realizable value and include all costs directly associated with manufacturing products: materials, labor, and manufacturing overhead. The components of inventories were as follows:

(in millions)February 22,2026May 25,2025
Raw materials and packaging$222.6$171.5
Finished goods751.4755.7
Supplies and other119.6108.2
Inventories$1,093.6$1,035.4
  1. PROPERTY, PLANT AND EQUIPMENT

The components of property, plant and equipment were as follows:

(in millions)February 22,2026May 25,2025
Land and land improvements$213.8$191.6
Buildings, machinery and equipment5,646.25,136.3
Furniture, fixtures, office equipment and other148.6161.9
Construction in progress266.2551.7
Property, plant and equipment, at cost6,274.86,041.5
Less accumulated depreciation(2,622.2)(2,353.6)
Property, plant and equipment, net$3,652.6$3,687.9

At February 22, 2026 and May 25, 2025, purchases of property, plant and equipment included in accounts payable were $70.5 million and $85.4 million, respectively.

The table below presents a breakdown of depreciation and amortization between Cost of sales (“COS”) and selling, general and administrative expenses (“SG&A”) for the thirteen and thirty-nine weeks ended February 22, 2026 and February 23, 2025.

Thirteen Weeks EndedThirty-Nine Weeks Ended
(in millions)February 22,2026February 23,2025February 22,2026February 23,2025
Depreciation - COS$84.9$83.9$253.8$242.0
Depreciation - SG&A3.74.110.411.1
$88.6$88.0$264.2$253.1
Amortization$8.2$8.5$24.1$23.2

Interest capitalized within construction in progress for the thirteen weeks ended February 22, 2026 and February 23, 2025, was $2.1 million and $4.2 million, respectively; and $9.1 million and $19.1 million for the thirty-nine weeks ended February 22, 2026 and February 23, 2025, respectively.

  1. GOODWILL AND OTHER IDENTIFIABLE INTANGIBLE ASSETS

The following table presents changes in goodwill balances, by segment, for the thirty-nine weeks ended February 22, 2026:

(in millions)North AmericaInternationalTotal
Balance at May 25, 2025$753.2$337.0$1,090.2
Foreign currency translation adjustment30.614.244.8
Balance at February 22, 2026$783.8$351.2$1,135.0

Other identifiable intangible assets were as follows:

February 22, 2026May 25, 2025
(in millions, except useful lives)Weighted Average Useful Life (in years)Gross Carrying AmountAccumulated AmortizationIntangibleAssets, NetWeighted Average Useful Life (in years)Gross Carrying AmountAccumulated AmortizationIntangibleAssets, Net
Non-amortizing intangible assets (a)n/a$18.0$—$18.0n/a$18.0$—$18.0
Amortizing intangible assets (b)12141.1(49.4)91.713140.8(44.8)96.0
$159.1$(49.4)$109.7$158.8$(44.8)$114.0

(a)Non-amortizing intangible assets represent brands and trademarks.

(b)Amortizing intangible assets are principally composed of licensing agreements, brands, and customer relationships. Foreign intangible assets are affected by foreign currency translation.

  1. OTHER ASSETS

The components of other assets were as follows:

(in millions)February 22,2026May 25,2025
Capitalized software costs$178.1$208.7
Equity method investments50.347.5
Property, plant and equipment deposits26.730.3
Other64.468.1
Other assets$319.5$354.6
  1. ACCRUED LIABILITIES

The components of accrued liabilities were as follows:

(in millions)February 22,2026May 25,2025
Compensation and benefits$155.1$104.5
Accrued trade promotions98.688.2
Dividends payable to shareholders52.851.7
Plant accruals31.923.0
Taxes payable29.137.3
Current portion of operating lease obligations28.123.9
Accrued interest23.436.3
Derivative liabilities and payables2.07.0
Other39.039.1
Accrued liabilities$460.0$411.0
  1. DEBT AND FINANCING OBLIGATIONS

The components of our debt, including financing obligations, were as follows:

(in millions) · February 22, 2026 · May 25, 2025
Amount · Interest Rate · Amount · Interest Rate
Short-term borrowings:
Revolving credit facility$236.43.830%$333.25.940%
Other credit facilities (a)32.837.6
269.2370.8
Long-term debt:
Term A-3 loan facility, due January 2030 (b)388.16.190405.06.900
Term A-4 loan facility, due May 2029 (b)300.66.690312.86.630
Term A-5 loan facility, due September 2031 (b)475.05.660493.85.650
RMB loan facility, due February 2027 (c)143.33.800143.84.040
RMB loan facility, due September 202920.43.80019.63.960
Euro term loan facility, due May 2029235.73.420227.24.510
4.875% senior notes, due May 2028500.04.875500.04.875
4.125% senior notes, due January 2030970.04.125970.04.125
4.375% senior notes, due January 2032700.04.375700.04.375
3,733.13,772.2
Financing obligations:
Lease financing obligations due on various dates through 20404.45.2
Total debt and financing obligations4,006.74,148.2
Debt issuance costs (d)(14.0)(16.8)
Short-term borrowings(269.2)(370.8)
Current portion of long-term debt and financing obligations(80.6)(77.8)
Long-term debt and financing obligations, excluding current portion$3,642.9$3,682.8

(a)Other credit facilities consist of short-term facilities at our subsidiaries used for working capital purposes. Borrowings under these facilities bear interest at various rates.

(b)Theinterest rates applicable to the Term A-3, A-4, and A-5 loans do not include anticipated patronage dividends. We have received and expect to continue receiving patronage dividends under these term loan facilities.

(c)The RMB loan facility matured on February 25, 2027.

(d)Excludes debt issuance costs of $3.2 million and $3.9 million as of February 22, 2026 and May 25, 2025, respectively, related to our revolving credit facility, which are recorded in “Other assets” on our Consolidated Balance Sheets.

As of February 22, 2026, we had $1,263.6 million of available liquidity under our revolving credit facility.

For the thirty-nine weeks ended February 22, 2026 and February 23, 2025, we paid $160.9 million and $167.2 million of interest on debt, respectively.

On January 30, 2026, we amended our term loan credit agreement with AgWest Farm Credit to remove adjustments to the Secured Overnight Financing Rate (SOFR).

For more information about our debt and financing obligations, interest rates, and debt covenants, see Note 8, Debt and Financing Obligations, of the Notes to Consolidated Financial Statements in “Part II, Item 8. Financial Statements and Supplementary Data” of the Form 10-K.

  1. FAIR VALUE MEASUREMENTS

The fair values of cash equivalents, receivables, accounts payable, and short-term debt approximate their carrying amounts due to their short duration.

The following table presents our financial assets and liabilities measured at fair value on a recurring basis based upon the level within the fair value hierarchy in which the fair value measurements fall:

(in millions)Level 1Level 2Level 3Fair Valueof Assets(Liabilities)
Derivative assets (a)$—$8.7$—$8.7
Derivative liabilities (a)—(2.0)—(2.0)
Deferred compensation liabilities (b)—(28.0)—(28.0)
Fair value, net$—$(21.3)$—$(21.3)
(in millions)Level 1Level 2Level 3Fair Valueof Assets(Liabilities)
Derivative assets (a)$—$10.2$—$10.2
Derivative liabilities (a)—(7.0)—(7.0)
Deferred compensation liabilities (b)—(27.0)—(27.0)
Fair value, net$—$(23.8)$—$(23.8)

(a)Derivative assets and liabilities included in Level 2 primarily represent commodity swaps, option contracts, and currency contracts. The fair value of these derivatives were determined using valuation models that use market observable inputs including both forward and spot prices. Derivative assets are presented within “Prepaid expenses and other current assets” on our Consolidated Balance Sheets and derivative liabilities are presented within “Accrued liabilities” on our Consolidated Balance Sheets.

(b)The fair values of our Level 2 deferred compensation liabilities were valued using third-party valuations, which are based on the net asset values of mutual funds in our retirement plans. While the underlying assets are actively traded on an exchange, the funds are not. Deferred compensation liabilities are primarily presented within “Other noncurrent liabilities” on our Consolidated Balance Sheets.

As of February 22, 2026, we had $2,945.6 million of fixed-rate and $1,056.7 million of variable-rate debt outstanding. Based on current market rates, the fair value of our fixed-rate debt was estimated to be $2,889 million as of February 22, 2026. Any differences between the book value and fair value are due to the difference between the period-end market interest rate and the stated rate of our fixed-rate debt. The fair value of our variable-rate term debt approximates the carrying amount and approximates current market prices.

  1. STOCKHOLDERS’ EQUITY

Share Repurchase Program

Our Board of Directors (the “Board”) has authorized a program, with no expiration date, to repurchase up to $750.0 million of our common stock. This authorization is open ended and repurchases under this share repurchase program may be made through open market transactions or pursuant to repurchase plans administered in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934.

Thirteen Weeks Ended · Thirty-Nine Weeks Ended
(in millions, except share and per share data) · February 22,2026 · February 22,2026
Common stock shares repurchased—804,882
Weighted average price per share$—$62.12
Total cost$—$50.0
Share repurchase plan, remaining authorized$308.0

Subsequent to February 22, 2026, we repurchased 1,053,429 shares of common stock for an aggregate purchase price of $43.7 million as of March 30, 2026. As of that date, approximately $264 million remained authorized for repurchase under our share repurchase program.

Dividends

During the thirty-nine weeks ended February 22, 2026, we paid $154.7 million of cash dividends to our common stockholders. We also paid an additional $52.8 million cash dividend on February 27, 2026, to stockholders of record as of January 30, 2026. On March 31, 2026, the Board declared a cash dividend of $0.38 per share, payable on June 5, 2026, to stockholders of record on May 8, 2026.

Accumulated Other Comprehensive Income

Changes in accumulated other comprehensive income, net of taxes, as of February 22, 2026, were as follows:

(in millions)ForeignCurrency Translation GainPension and Post-RetirementBenefitsOtherAccumulatedOtherComprehensiveIncome
Balance as of May 25, 2025$58.9$(4.6)$0.2$54.5
Other comprehensive income before reclassifications, net of tax83.35.1—88.4
Net current-period other comprehensive income83.35.1—88.4
Balance as of February 22, 2026$142.2$0.5$0.2$142.9
  1. SEGMENTS

We manage our operations intwo business segments, North America and International. As a result of how we manage the business, we havetwo operating segments, each of which is a reportable segment: North America and International. North America includes activity that occurs in the United States, Canada, and Mexico. International includes all activity that does not occur within the North America segment. Both segments primarily manufacture frozen potato products for sale to our customers. These reportable segments are each managed by a general manager and supported by a cross-functional team assigned to support the segment.

Our president and chief executive officer is our chief operating decision maker (the “CODM”). The CODM assesses the performance of our reportable segments and decides how to allocate resources based on segment adjusted earnings before interest, taxes, depreciation, and amortization (“EBITDA”). The adjustments to EBITDA include unrealized mark-to-market derivative gains and losses (which are a component of both cost of sales and selling, general and administrative expenses), foreign currency exchange gains and losses (which are a component of selling, general and administrative expenses), blue chip swap transaction gains (which are a component of selling, general and administrative expenses), stock-based compensation expense (which is a component of selling, general and administrative expenses), and other items impacting comparability (which are a component of both cost of sales and selling, general and administrative expenses) that are described below (“Segment Adjusted EBITDA”).

Net sales and Segment Adjusted EBITDA inform operating decisions, performance assessment, and resource allocation decisions at the segment level. Our CODM uses net sales and Segment Adjusted EBITDA in the annual operating plan and forecasting process and considers actual versus plan variances in assessing the performance of each segment. Total asset information by segment is not regularly provided to our CODM or utilized for purposes of assessing performance or allocating resources by segment and, as a result, such information has not been presented below.

The following table illustrates reportable segment net sales and Segment Adjusted EBITDA for the thirteen and thirty-nine weeks ended February 22, 2026 and February 23, 2025, respectively.

Thirteen Weeks Ended
February 22,2026 · February 23,2025
(in millions) · North America · International · Total · North America · International · Total
Net sales$1,035.0$529.8$1,564.8$986.3$534.2$1,520.5
Other segment items (a)745.2511.31,256.5683.7440.11,123.8
Segment Adjusted EBITDA (b)$289.8$18.5$308.3$302.6$94.1$396.7
Unallocated corporate costs (c)(36.6)(23.7)
Depreciation and amortization (d)98.998.5
Unrealized derivative gains(11.0)(5.9)
Foreign currency exchange (gains) losses(11.5)7.0
Blue chip swap gains (e)—(0.6)
Stock-based compensation10.59.2
Items impacting comparability:
Cost Savings Program, Restructuring Plan, and other expenses (f)55.510.3
Shareholder activism expense (g)—3.7
Interest expense, net45.047.3
Income before income taxes84.3203.5
Income tax expense30.357.5
Net income$54.0$146.0

(a)Other segment items include cost of sales; selling, general and administrative expenses; and equity method investment income or loss for each segment.

(b)Segment Adjusted EBITDA for the thirteen weeks ended February 23, 2025, included an approximately $9 million benefit ($7 million after-tax) related to a voluntary product withdrawal initiated in the fourth quarter of fiscal 2024. This includes an approximately $6 million benefit ($5 million after-tax) in net sales and an approximately $3 million benefit ($2 million after-tax) in cost of sales. North America included approximately $3 million of the total benefit and International included approximately $6 million of total benefit.

International Segment Adjusted EBITDA for the thirteen weeks ended February 22, 2026 included a net $32.5 million charge for the write-off of excess raw potatoes.

(c)Unallocated corporate costs include costs related to corporate support staff and support services, which include, but are not limited to, our administrative, information technology, human resources, finance, and accounting functions that are not specifically allocated to the segments. In the table, unallocated corporate costs exclude unrealized derivative gains and losses, foreign currency exchange gains and losses, blue chip swap transaction gains, stock-based compensation expense, and other items impacting comparability. These items are added back to reconcile Segment Adjusted EBITDA to net income.

(d)Depreciation and amortization includes interest expense, income tax expense, and depreciation and amortization relating to equity method investments of $2.1 million and $2.0 million for the thirteen weeks ended February 22, 2026 and February 23, 2025, respectively.

(e)We entered into blue chip swap transactions to transfer U.S. dollars into Argentina primarily related to funding our capacity expansion in Argentina, which is now complete. The blue chip swap rate can diverge significantly from Argentina’s official exchange rate.

(f)Cost Savings Program, Restructuring Plan, and other expenses relate to costs incurred under the Plans. See Note 4, Cost Savings Program and Restructuring, of these Condensed Notes to Consolidated Financial Statements for additional information.

(g)Represents advisory fees related to shareholder activism matters.

Thirty-Nine Weeks Ended
February 22,2026 · February 23,2025
(in millions) · North America · International · Total · North America · International · Total
Net sales$3,189.1$1,653.1$4,842.2$3,162.1$1,613.4$4,775.5
Other segment items (a)2,351.51,550.23,901.72,312.31,419.33,731.6
Segment Adjusted EBITDA (b)$837.6$102.9$940.5$849.8$194.1$1,043.9
Unallocated corporate costs (c)(81.0)(77.3)
Depreciation and amortization (d)294.8282.4
Unrealized derivative gains(3.8)(11.8)
Foreign currency exchange (gains) losses(9.4)17.2
Blue chip swap gains (e)—(20.5)
Stock-based compensation30.631.0
Items impacting comparability:
Cost Savings Program, Restructuring Plan, and other expenses (f)101.5169.4
Shareholder activism expense (g)4.04.1
Pension settlement (h)14.2—
Interest expense, net133.0135.8
Income before income taxes294.6359.0
Income tax expense114.2121.7
Net income$180.4$237.3

(a)Other segment items include cost of sales; selling, general and administrative expenses; and equity method investment income or loss for each segment.

(b)Segment Adjusted EBITDA for the thirty-nine weeks ended February 23, 2025, includes an estimated $31 million charge ($24 million after-tax) related to the voluntary product withdrawal that was initiated in the fourth quarter of fiscal 2024. This includes an approximately $9 million loss ($7 million after-tax) in net sales and an approximately $22 million charge ($17 million after-tax) in cost of sales. The total charge to reporting segments was approximately $19 million to the North America segment and approximately $12 million to the International segment.

International Segment Adjusted EBITDA for the thirty-nine weeks ended February 22, 2026 included a net $45.6 million charge for the write-off of excess raw potatoes.

(c)Unallocated corporate costs include costs related to corporate support staff and support services, which include, but are not limited to, our administrative, information technology, human resources, finance, and accounting functions that are not specifically allocated to the segments. In the table, unallocated corporate costs exclude unrealized derivative gains and losses, foreign currency exchange gains and losses, blue chip swap transaction gains, stock-based compensation expense, and other items impacting comparability. These items are added back to reconcile Segment Adjusted EBITDA to net income.

(d)Depreciation and amortization includes interest expense, income tax expense, and depreciation and amortization relating to equity method investments of $6.5 million and $6.1 million for the thirty-nine weeks ended February 22, 2026 and February 23, 2025, respectively.

(e)We entered into blue chip swap transactions to transfer U.S. dollars into Argentina primarily related to funding our capacity expansion in Argentina, which is now complete. The blue chip swap rate can diverge significantly from Argentina’s official exchange rate.

(f)Cost Savings Program, Restructuring Plan, and other expenses relate to costs incurred under the Plans. See Note 4, Cost Savings Program and Restructuring, of these Condensed Notes to Consolidated Financial Statements for additional information.

(g)Represents advisory fees related to shareholder activism matters.

(h)The Pension settlement charge was to fully fund the Company’s defined benefit pension plan, enabling lump sum payments to participants and transferring the remaining obligations and related plan assets to an insurer through a group annuity contract.

  1. COMMITMENTS, CONTINGENCIES, GUARANTEES AND LEGAL PROCEEDINGS

We have financial commitments and other obligations that arise in the ordinary course of our business. These include long-term debt, lease obligations, and purchase commitments for goods and services. There have been no material changes to the commitments, contingencies, and guarantees disclosed in Note 14, Commitments, Contingencies, Guarantees, and Legal Proceedings, of the Notes to Consolidated Financial Statements in “Part II, Item 8. Financial Statements and Supplementary Data” of the Form 10-K.

Legal Proceedings

In June 2024, two putative class actions were filed in the U.S. District Court for the District of Idaho against the Company and certain of our current and former executive officers alleging violations of the federal securities laws. The lawsuits were consolidated in November 2024. The amended consolidated complaint alleges the defendants made misrepresentations and omissions regarding the design and implementation of our enterprise resource planning system and the Company’s pricing practices. The complaint asserts claims on behalf of a proposed class of purchasers of the Company’s common stock between July 25, 2023 and December 19, 2024. On April 25, 2025, defendants filed a motion to dismiss. Briefing is complete and the motion remains pending. In June 2025, a purported Company stockholder filed a verified stockholder derivative complaint (nominally on behalf of the Company) against certain of our current and former directors and officers, alleging violations of the federal securities laws and breach of fiduciary duty stemming from the same or similar purported misrepresentations and omissions regarding the design and implementation of our enterprise resource planning system as the putative class actions. The derivative lawsuit has been stayed pending resolution of the motion to dismiss in the securities class action. We believe the lawsuits lack merit and intend to vigorously defend against the allegations. We are currently unable to predict the outcome of this matter or estimate the range of potential loss, if any, that may result.

In November 2024, a class action complaint was filed in the U.S. District Court for the Northern District of Illinois against the Company, certain of our subsidiaries and a number of other producers of frozen potato products alleging violations of antitrust laws. Additional class action complaints were later filed in the same court, based on similar allegations, bringing antitrust claims on behalf of putative classes of direct purchasers, commercial and institutional indirect purchasers, and end-consumer indirect purchasers. Some complaints named additional defendants. The complaints were ordered to be consolidated and amended. On October 6, 2025, plaintiffs filed three consolidated complaints on behalf of their putative classes, asserting amended claims against the Company, certain of our subsidiaries, other producers of frozen potato products, and a data provider. The consolidated complaints allege, among other things, that beginning at least as early as January 1, 2021, the defendants conspired to raise the price of frozen potato products above competitive levels in violation of U.S. antitrust laws by coordinating prices of frozen potato products and imposing lockstep price increases, allegedly facilitated by the exchange of non-public information about prices and production. The complaints on behalf of the putative classes of indirect purchasers also assert claims under various state laws, including state antitrust laws, unfair competition laws, and consumer protection statutes. The relief sought in the complaints includes treble damages, injunctive relief, equitable monetary relief, pre- and post-judgment interest, costs and attorneys’ fees. On December 5, 2025, defendants filed a motion to dismiss. Briefing is complete and the motion remains pending. Class actions based on similar allegations have also been filed in Canada, in the Supreme Court of British Columbia and the Superior Court of Quebec. On December 15, 2025, the Superior Court of Quebec terminated the Quebec action due to lack of service. We believe these complaints lack merit and intend to vigorously defend against the allegations. We are currently unable to predict the outcome of this matter or estimate the range of potential loss, if any, that may result.

We are also a party to various other legal actions arising in the ordinary course of our business. These claims, legal proceedings and litigation principally arise from alleged casualty, product liability, employment, and other disputes. In determining loss contingencies, we consider the likelihood of loss as well as the ability to reasonably estimate the amount of such loss or liability. An estimated loss is recognized when it is considered probable that a liability has been incurred and when the amount of loss can be reasonably estimated. While any claim, proceeding or litigation has an element of uncertainty, we believe the outcome of any of these that are pending or threatened will not have a material adverse effect on our financial condition, results of operations, or cash flows.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.